Literatur
-
1
Priori G S, Napolitano C, Schwartz P J.
Low penetrance in the long-QT-syndrome: clinical impact.
Circulation.
1999;
99
529-533
-
2
Haffner S, Thürmann P A.
Unerwünschte Arzneimittelwirkungen: QT-Verlängerungen und Torsade-de-Pointes-Arrhythmien.
Dtsch Med Wochenschr.
2002;
127
1022-1024
-
3
De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N.
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
Drug Saf.
2002;
25
263-286
-
4
Yeragani V K, Pohl R, Jampala V C, Balon R, Kay J, Igel G.
Effect of posture and isoproterenol on beat-to-beat heart rate and QT variability.
Neuropsychobiology.
2000;
41
113-123
-
5
Shimizu W, Ohe T, Kurita T, Takaki H, Aihara N, Kamakura S, Matsuhisa M, Shimomura K.
Early afterdepolarisations induced by isoproterenol in patients with congenital long QT syndrome.
Circulation.
1991;
84
1915-1923
Autor
Dr. Steffen Haffner
Philipp Klee-Institut für klinische Pharmakologie, HELIOS Klinikum Wuppertal
Heusnerstraße 40
42283 Wuppertal
Phone: 0202/8961854
Fax: 0202/8961852
Email: shaffner@wuppertal.helios-kliniken.de
